Acacia Pharma raises £15 million to advance clinical development of lead products for supportive care
Advertisement
Acacia Pharma announced it has raised £15 million (~$23.5 million) in a Series B financing led by Fidelity Biosciences and Novo A/S. Current investors Gilde Healthcare and Lundbeckfond Ventures also participated in the round. Dr Alex Pasteur of Fidelity Biosciences and Dr Martin Edwards of Novo A/S have joined the Board of Acacia Pharma as Non-executive Directors.
Acacia Pharma will use the proceeds to:
- complete Phase III development of APD421 for the prevention of post-operative nausea & vomiting (PONV);
- complete Phase II development of APD403 for the prevention of chemotherapy induced nausea & vomiting (CINV); and
- develop the commercial presentation of APD515 for the treatment of xerostomia (dry mouth) in advanced cancer patients.
Most read news
Other news from the department research and development
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Pronova BioPharma appoints Per-Oluf Olsen as new CEO
Mucosis Receives Financial Support from the Dutch Government for Its Flugem Program
Researchers find way to kill pathogen resistant to antibiotics
VTT has developed a rapid image analysis method to help diagnose Alzheimer's disease
A lab in your pocket
How brain areas communicate shapes human communication - The hearing regions in your brain form new alliances as you try to listen at the cocktail party
New method for protein analysis - The process can be used universally without the need for expensive special equipment
© 1997-2025 LUMITOS AG, All rights reserved